On September 8, 2025, CONMED Corp appointed Kim Kelderman as a director, granting him a prorated equity compensation worth approximately $134,766 that will vest on September 8, 2026. Mr. Kelderman is considered independent and joins the Corporate Governance and Nominating Committee and the Strategy Committee.